— MoneyGram International Inc. (NASDAQ: MGI) reported Q3 2019 loss of $0.03 per share, vs. EPS of $0.03 expected.
— Revenues fell 6% to $325 million, vs. $334 million expected.
— Money transfer revenue was $285 million.
— Investment revenue was $13.4 million.
— Total digital transactions represented 20% of money transfer transactions.
— Q4 2019 total revenue is expected to be approx. $330 million.
— MGI shares were up 0.76% in premarket hours on Friday.
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key